113 related articles for article (PubMed ID: 7563711)
21. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
[TBL] [Abstract][Full Text] [Related]
22. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of occult hepatitis C without the need for a liver biopsy.
Castillo I; Bartolomé J; Quiroga JA; Barril G; Carreño V
J Med Virol; 2010 Sep; 82(9):1554-9. PubMed ID: 20648609
[TBL] [Abstract][Full Text] [Related]
24. A highly sensitive and specific enzyme-linked immunosorbent assay of antibodies to hepatitis C virus.
Eroglu C; Yildiz E; Ozturk M; Pinarbasi E
Acta Virol; 2000 Feb; 44(1):29-33. PubMed ID: 10989689
[TBL] [Abstract][Full Text] [Related]
25. Comparison of prevalence of anti-hepatitis C virus antibodies in differing South American populations.
Robinson JW; Rosas M; Guzman F; Patarroyo ME; Moreno A
J Med Virol; 1996 Oct; 50(2):188-92. PubMed ID: 8915886
[TBL] [Abstract][Full Text] [Related]
26. Anti-HCV core antibody: a potential new marker of occult and otherwise serologically silent HCV infection.
Michalak TI; Pham TN
J Hepatol; 2009 Feb; 50(2):244-6. PubMed ID: 19070918
[No Abstract] [Full Text] [Related]
27. [A follow up study of patients who received blood positive for hepatitis C virus core antibody, with genetic evidence of hepatitis C virus transmission].
Watanabe M; Ohkosi S; Asakura H; Kamimura T
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):389-94. PubMed ID: 7563766
[No Abstract] [Full Text] [Related]
28. Simultaneous detection of anti-HCV antibody and HCV core antigen.
Ansaldi F; Icardi G
Methods Mol Biol; 2009; 510():15-23. PubMed ID: 19009250
[TBL] [Abstract][Full Text] [Related]
29. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
30. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection.
Kanno A; Kazuyama Y
J Med Virol; 2002 Oct; 68(2):229-33. PubMed ID: 12210412
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus core protein fused to hepatitis B virus core antigen for serological diagnosis of both hepatitis C and hepatitis B infections by ELISA.
Wu CL; Leu TS; Chang TT; Shiau AL
J Med Virol; 1999 Feb; 57(2):104-10. PubMed ID: 9892392
[TBL] [Abstract][Full Text] [Related]
32. [Clinical value of the detection of hepatitis C virus core antigen].
Lu YC; Jiang ZY; Kuang YL; Chen WS; Tan YZ; Li DR
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):635-7. PubMed ID: 17618587
[TBL] [Abstract][Full Text] [Related]
33. [Diagnostic tests: Hepatitis C virus-related antibody].
Tanaka T
Nihon Rinsho; 2005 Jul; 63 Suppl 7():411-4. PubMed ID: 16111288
[No Abstract] [Full Text] [Related]
34. [Usefulness of HCV-ELISA using synthetic peptide].
Takahashi T; Hayashi N; Shikata T
Nihon Rinsho; 1991 Feb; 49(2):347-50. PubMed ID: 1849192
[No Abstract] [Full Text] [Related]
35. Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid.
Gutierrez JA; Klepper AL; Garber J; Walewski JL; Bateman K; Khaitova V; Syder A; Tscherne DM; Gauthier A; Jefferson D; Rice CM; Schiano TD; Branch AD
J Virol Methods; 2011 Jan; 171(1):169-75. PubMed ID: 21034775
[TBL] [Abstract][Full Text] [Related]
36. [Serotypes of hepatitis C virus defined by antibodies directed to the putative core protein].
Nakamura H; Miyakawa H; Kako M
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):271-5. PubMed ID: 7563721
[No Abstract] [Full Text] [Related]
37. [Hepatitis C virus-related antibody].
Tanaka T
Nihon Rinsho; 1999 Nov; 57 Suppl():350-2. PubMed ID: 10635854
[No Abstract] [Full Text] [Related]
38. Evaluation of quantitative assay for antibody to hepatitis C virus core in patients treated with interferon.
Yoshimura E; Hayashi J; Kishihara Y; Yamaji K; Kinukawa N; Kashiwagi S
Dig Dis Sci; 1996 Jan; 41(1):155-60. PubMed ID: 8565749
[TBL] [Abstract][Full Text] [Related]
39. [Indication of hepatitis C virus antibodies with separation into IgM and IgG classes and its clinical significance].
Afanas'ev AIu
Klin Lab Diagn; 1996; (2):43-4. PubMed ID: 8680774
[TBL] [Abstract][Full Text] [Related]
40. HCV core IgM and IgG antibodies in blood donors.
Kapprell HP; Majnak A; Medgyesi GA; Szabó JE; Michel G; Albrecht M; Heyermann H; Hampl H; Troonen H
Vox Sang; 1995; 68(1):57-8. PubMed ID: 7536991
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
